REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $142,000 | -85.4% | 49,231 | -64.8% | 0.01% | -85.7% |
| Q1 2016 | $970,000 | -47.0% | 140,000 | -33.3% | 0.05% | -51.5% |
| Q4 2015 | $1,831,000 | -21.5% | 210,000 | -41.1% | 0.10% | +5.2% |
| Q3 2015 | $2,332,000 | -38.3% | 356,504 | +3.4% | 0.10% | -30.4% |
| Q2 2015 | $3,778,000 | -14.5% | 344,667 | +32.1% | 0.14% | -25.0% |
| Q1 2015 | $4,420,000 | -21.8% | 260,930 | -25.9% | 0.18% | +2.8% |
| Q4 2014 | $5,651,000 | – | 352,278 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |